Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

Clinical trial NCT04438382 · TERMINATED

Trial details

NCT number: NCT04438382
Sponsor: ECOG-ACRIN Cancer Research Group
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm Steroid-Refractory Pneumonitis

Start date: 2021-01-07
Primary completion: 2023-12-21
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.